Abstract

http://ssrn.com/abstract=1616625
 
 

Footnotes (83)



 


 



American Needle and the Boundaries of the Firm in Antitrust Law


Herbert J. Hovenkamp


University of Iowa - College of Law

August 15, 2010


Abstract:     
In American Needle the Supreme Court unanimously held that for the practice at issue the NFL should be treated as a “combination” of its teams rather than a single entity. However, the arrangement must be assessed under the rule of reason. The opinion, written by Justice Stevens, was almost certainly his last opinion for the Court in an antitrust case; Justice Stevens had been a dissenter in the Supreme Court’s Copperweld decision 25 years earlier, which held that a parent corporation and its wholly owned subsidiary constituted a single “firm” for antitrust purposes. The Sherman Act speaks to this issue but is not very helpful. Its § 6 defines the word “person” to “include corporations and associations existing under or authorized by” law, but gives no particulars.

When antitrust tribunals decide if associations should be considered a single firm or a combination two factors stand out. One is whether the members remain as separate, significant economic actors in the marketplace. The ordinary corporation's shareholders do not and are thus unlike the members of a trade association, sports league, or the like. The second key factor is whether the challenged act controls or affects the individual market behavior of the members. In American Needle the conduct was exclusive licensing of the individually held trademark rights of each of the NFL’s member teams. These rights had been consolidated into a single holding company controlled by the NFL and then licensed exclusively to Reebok, thus ousting the plaintiff.

While American Needle is important, its did not necessarily present the problems of antitrust micromanagement that concerned the Court. If the NFL were a single entity the case would be characterized as exclusive dealing, or more properly an output contract, in which the NFL licensed to Reebok and no one else. Such agreements are analyzed under the rule of reason and their illegality usually depends on a “foreclosure” analysis in which illegality depends on the extent to which the plaintiff has been denied access to a properly defined relevant market. Also significant is that American Needle involves a trademark license, and the justification for restricted licensing of trademarks can be weighty, particularly if issues of origin or quality control are present. Even if exclusive trademark licenses are desirable, however, each separate NFL team could have granted its own individual exclusive licenses, and apparel manufacturers could then compete for one or more of these contracts.

Finally, the American Needle decision has important implications for other collaborative entities, including Visa and Mastercard, real estate associations, and hospitals whose staff members have independent practices. The relevant question in these cases is not whether otherwise competing firms control the activities of the collaborative entity, but rather whether the collaborative entity controls their independent business activities.

Number of Pages in PDF File: 19

Keywords: Antitrust, Copperweld, Single Entity, Conspiracy, Cartel, Price Fixing, Intellectual Property, Licensing, Firm, Supreme Court

JEL Classification: K10, K21, L100, L12, L21, L23, L25

working papers series


Download This Paper

Date posted: May 29, 2010 ; Last revised: August 15, 2010

Suggested Citation

Hovenkamp, Herbert J., American Needle and the Boundaries of the Firm in Antitrust Law (August 15, 2010). Available at SSRN: http://ssrn.com/abstract=1616625 or http://dx.doi.org/10.2139/ssrn.1616625

Contact Information

Herbert J. Hovenkamp (Contact Author)
University of Iowa - College of Law ( email )
407 Boyd Law Building
Iowa City, IA 52242
United States
319-335-9079 (Phone)
Feedback to SSRN


Paper statistics
Abstract Views: 3,341
Downloads: 609
Download Rank: 22,987
Footnotes:  83

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo5 in 0.484 seconds